Retrograde Robotic Radical Prostatectomy: Description of a New Technique and Early Perioperative Outcomes
Table 1
Preoperative, operative, and postoperative patient demographics and outcomes for 18 patients undergoing retrograde robotic-assisted laparoscopic prostatectomy.
Patient and procedure variables
Outcome
Preoperative
Mean age, years (range)
59 (42–76)
Mean BMI, kg/m2 (range)
28 (21–37)
Mean PSA, ng/mL (range)
6.0 (1.2–23.0)
Mean IPSS (median)
8 (8)
Mean SHIM (median)
19 (23)
Biopsy Gleason score
6 ()
7 ()
8 ()
Clinical T stage
T1c ()
T2a ()
Operative
Mean operative time, min (range)
198 (150–300)
Mean robotic console time, min (range)
168 (118–265)
Nerve-sparing procedure
Total ()
Partial ()
None ()
Bladder-neck sparing procedure
Yes ()
No ()
Pelvic lymph node dissection
Yes ()
No ()
Mean EBL, mL (range)
142 (40–300)
Postoperative
Final Gleason score
6 ()
7 ()
8 ()
Multifocal cancer
Yes ()
No ()
Margin status
Negative ()
Positive ()
Location of positive margin
Bladder neck ()
Apex ()
Lymph node invasion
Yes ()
No ()
Unknown ()
Pathologic T stage
T2a ()
T2c ()
T3a ()
T3b ()
Mean hospital stay, days (range)
2 (1–3)
Transfusions
None
30-day complications
BMI: Body Mass Index, PSA: Prostate Specific Antigen, IPSS: International Prostate Symptom Score, SHIM: Sexual Health Inventory for Men, and EBL: estimated blood loss. Both patients with deep-vein thrombosis.